Terms: = Colorectal cancer AND SMAD4, JIP, Q13485, 4089, ENSG00000141646, MADH4, DPC4 AND Staging
15 results:
1. Prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
[TBL] [Abstract] [Full Text] [Related]
2. Tumour genotypes account for survival differences in right- and left-sided colon cancers.
Ward TM; Cauley CE; Stafford CE; Goldstone RN; Bordeianou LG; Kunitake H; Berger DL; Ricciardi R
Colorectal Dis; 2022 May; 24(5):601-610. PubMed ID: 35142008
[TBL] [Abstract] [Full Text] [Related]
3. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
[TBL] [Abstract] [Full Text] [Related]
4. High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Ge W; Hu H; Cai W; Xu J; Hu W; Weng X; Qin X; Huang Y; Han W; Hu Y; Yu J; Zhang W; Ye S; Qi L; Huang P; Chen L; Ding K; Wang LD; Zheng S
Int J Cancer; 2020 Apr; 146(7):2027-2035. PubMed ID: 31693169
[TBL] [Abstract] [Full Text] [Related]
5. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
[TBL] [Abstract] [Full Text] [Related]
6. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
[TBL] [Abstract] [Full Text] [Related]
7. SMAD-4 gene expression in human colorectal cancer: Comparison with some clinical and pathological parameters.
Wosiak A; Wodziński D; Kolasa M; Sałagacka-Kubiak A; Balcerczak E
Pathol Res Pract; 2017 Jan; 213(1):45-49. PubMed ID: 27914767
[TBL] [Abstract] [Full Text] [Related]
8. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.
Roth AD; Delorenzi M; Tejpar S; Yan P; Klingbiel D; Fiocca R; d'Ario G; Cisar L; Labianca R; Cunningham D; Nordlinger B; Bosman F; Van Cutsem E
J Natl Cancer Inst; 2012 Nov; 104(21):1635-46. PubMed ID: 23104212
[TBL] [Abstract] [Full Text] [Related]
10. Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
Lips EH; van Eijk R; de Graaf EJ; Oosting J; de Miranda NF; Karsten T; van de Velde CJ; Eilers PH; Tollenaar RA; van Wezel T; Morreau H
BMC Cancer; 2008 Oct; 8():314. PubMed ID: 18959792
[TBL] [Abstract] [Full Text] [Related]
11. Progression and tumor heterogeneity analysis in early rectal cancer.
Lips EH; van Eijk R; de Graaf EJ; Doornebosch PG; de Miranda NF; Oosting J; Karsten T; Eilers PH; Tollenaar RA; van Wezel T; Morreau H
Clin Cancer Res; 2008 Feb; 14(3):772-81. PubMed ID: 18245538
[TBL] [Abstract] [Full Text] [Related]
12. Effect of dpc4 gene on invasion and metastasis of colorectal carcinoma cells.
Xiao DS; Wen JF; Li JH; Wang KS; Hu ZL; Zhou JH; Deng ZH; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2006 Dec; 38(12):883-92. PubMed ID: 17151782
[TBL] [Abstract] [Full Text] [Related]
13. [Genetic factors and colorectal cancers development: therapeutic impact].
Olschwang S; Viret F; Monges G; Seitz J; Sevenet N; Tiret E; Milano G; Birnbaum D; Bertucci F
Med Sci (Paris); 2006 Jan; 22 Spec No 1():45-9. PubMed ID: 16705943
[TBL] [Abstract] [Full Text] [Related]
14. Transforming growth factor-beta suppresses nonmetastatic colon cancer through smad4 and adaptor protein ELF at an early stage of tumorigenesis.
Tang Y; Katuri V; Srinivasan R; Fogt F; Redman R; Anand G; Said A; Fishbein T; Zasloff M; Reddy EP; Mishra B; Mishra L
Cancer Res; 2005 May; 65(10):4228-37. PubMed ID: 15899814
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver.
Hornick JL; Lauwers GY; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):381-9. PubMed ID: 15725808
[TBL] [Abstract] [Full Text] [Related]
